HR 3668 112th Congress House Crime and Law Enforcement Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Fraud offenses and financial crimes Prescription drugs

Counterfeit Drug Penalty Enhancement Act of 2012

Introduced: December 14, 2011 See on congress.gov

Everywhere this bill has been 16 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 19, 2012

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Jun 18, 2012

Motion to reconsider laid on the table Agreed to without objection.

Jun 18, 2012

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3719)

Jun 18, 2012

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H3719)

Jun 18, 2012

DEBATE - The House proceeded with forty minutes of debate on H.R. 3668.

Jun 18, 2012

Considered under suspension of the rules. (consideration: CR H3719-3721)

Jun 18, 2012

Mr. Smith (TX) moved to suspend the rules and pass the bill, as amended.

Jun 18, 2012

Placed on the Union Calendar, Calendar No. 385.

Jun 18, 2012

Reported (Amended) by the Committee on Judiciary. H. Rept. 112-537.

Jun 6, 2012

Ordered to be Reported (Amended) by Voice Vote.

Jun 6, 2012

Committee Consideration and Mark-up Session Held.

Jun 5, 2012

Subcommittee on Crime, Terrorism, and Homeland Security Discharged.

Mar 28, 2012

Subcommittee Hearings Held.

Jan 6, 2012

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Dec 14, 2011

Referred to the House Committee on the Judiciary.

Dec 14, 2011

Introduced in House

Plain-English summary Congressional Research Service

Counterfeit Drug Penalty Enhancement Act of 2012 - Amends the federal criminal code to prohibit and to establish criminal penalties for trafficking, or attempting to traffic, in counterfeit drugs.

Directs: (1) the Attorney General to give increased priority to efforts to investigate and prosecute offenses that involve trafficking in counterfeit drugs; and (2) the United States Sentencing Commission to review and, if appropriate, amend its guidelines and policy statements applicable to persons convicted of such offense to reflect congressional intent that penalties be increased to reflect the serious nature of such offense and the need for an effective deterrent and to account for the resulting harm to the public.

What's happening now June 19, 2012

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Committees of jurisdiction 3